MedEsthetics Cover Profile July/August 2017
Wendy Roberts, MD, has developed a devoted following by helping her patients maintain and improve their skin health from head to toe.

When Wendy Roberts, MD, applied to Sarah Lawrence College in New York, a career in medicine was far from her mind. “I was going to major in dance,” she says. “I danced for the Dance Theatre of Harlem and the Garden State Ballet.”

Once enrolled at Sarah Lawrence, however, her dream hit a snag that changed the course of her career. A number of students had matriculated early and snapped up all the...


MedEsthetics Cover Profile July/August 2017

When Wendy Roberts, MD, applied to Sarah Lawrence College in New York, a career in...

Understanding Laser Contracts

Laser treatments have become a staple of the medical aes­thetics industry. More than 2...

e-Commerce Considerations

THE INTERNET HAS changed the way people shop. Today, consumers go online to purchase...

Staphylococcus aureus

In an effort to provide guidance to prescribers and encourage further research on the...


Biopelle antiaging eye treatment

The Tensage Growth Factor + Stem Cell Dual Eye Care Kit from Biopelle is a...

Safer sclerotherapy injections

The ergonomic SyrEase Syringe Adaptor from Syris Scientific allows providers...

Titanium and zinc oxide sun protection.

Epionce Daily Shield Lotion Tinted SPF 50 provides all skin types—including...

Antiaging Skin Care

Induction Therapies P.R.R. Protein Rich Retinol 1.0%, 4.0% and 8.0% feature...


Facebook Ad Leads
By Angela (Miller) Hamilton, Facebook Marketing Expert at ReachLocal With more than 1.71 billion active users on Facebook, social media advertising is an important way for medspas and medical practices to reach local consumers online. Most facilties have a company page and perhaps purchase a few...
Addressing Employee Tardiness
By Paul Edwards, CEO of CEDR HR Solutions There’s nothing more maddening than knowing your patients are due to arrive at your door at any moment, but because one or more of your employees STILL hasn’t shown up for work, you won’t be able to take the patients back right away. Despite the many...
Allergan CEO Questions Medical Aesthetic Treatment for Minors

Allergan Chairman and CEO Brent Saunders authored a blog post from the CEO on the company’s website in which he shared his concern and discomfort with the growing number of minors undergoing cosmetic enhancement. In the post, he encouraged the medical aesthetics industry to start a dialogue on this topic in an effort to find consensus and provide guidelines for the treatment of minors. Following is Saunder’s post in full:

As the father of two high school age girls, I am sensitive to the societal pressures they face – to look a certain way or meet a certain standard. And as the leader of Allergan, I appreciate how medical aesthetic technologies can provide safe, effective treatments for patients who seek the benefits of improving their appearance. But when these two worlds intersect – through the inappropriate use of medical aesthetic procedures among minors – it is time to speak up.

To be clear, Allergan’s medical aesthetic products are approved for adults.

There is growing interest by younger patients—teenagers under the age of 18—to try aesthetic treatments. For instance, a YouTube search for “teen lip injections” returns more than 50,000 videos, and data shows teenage use of soft tissue fillers and...

Nitric Oxide-Based Acne Treatment Effective in Adolescents With Acne Vulgaris

Novan Pharmaceutical’s SB204, an investigational once-daily, topical nitric oxide-based monotherapy for the treatment of acne vulgaris, showed superior efficacy to placebo and a high level of safety in a phase 3 pivotal trial focused on adolescent use.

The company presented pharmacokinetic, safety and efficacy data from the trial at the 13th World Congress of Pediatric Dermatology in Chicago, Illinois, last week. In the two replicate, multi-center, randomized, double-blinded, vehicle-controlled, parallel group trials, a total of 2,639 patients ages 9 and older with moderate to severe acne were enrolled across 110 sites in the United States. Overall results showed a statistically significant reduction in inflammatory, non-inflammatory and total lesion with SB204 4% compared to vehicle, while maintaining a favorable safety and tolerability profile.

In a post-hoc analysis of a subset of 905 adolescents ranging from ages 9 to under 17 years old treated topically with SB204 Gel 4% once-daily (n=439) or vehicle gel once-daily (n=466) for 12 weeks, the company found the following results:

  • The percent change from baseline in the number of non-inflammatory lesions was -33.4% for SB204 and -24.2%...
In Memoriam: Rhinoplasty Pioneer Jack Gunter, MD

Plastic surgeon Jack Gunter, MD, died on Tuesday, July 11 at the age of 79, in Dallas. He was the founder of the Gunter Center for Aesthetics & Cosmetic Surgery, which he ran until retirement in 2014, and was widely recognized as a pioneer in the advancement of rhinoplasty procedures and a champion of the open approach to rhinoplasty.

In the early 1980s, Dr. Gunter identified a need in plastic surgery training, and in 1983, he and Robert Oneal, MD, held the first of the rhinoplasty-focused training sessions that would soon become known as the world-renowned Dallas Rhinoplasty Symposium, which celebrated its 34th year last March. Through the symposium, he is credited with educating more than 10,000 surgeons globally in the art of rhinoplasty.

“Jack Gunter literally taught and influenced an entire generation of rhinoplasty experts in both plastic surgery and facial plastic surgery,” says his long-time colleague Rod Rohrich, MD. “His candor, humor and his skill were always focused upon us to be the best we could be each day. His legacy lives on in all of us whenever we perform a rhinoplasty.”

“He was a true giant in plastic surgery,” says American Society of Plastic Surgery President-elect...

Biologic Therapy Dupixent (Dupilumab) Approved For Atopic Dermatitis

The U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) Injection from Regeneron Pharmaceuticals, and Sanofi for the treatment of adults with moderate-to-severe atopic dermatitis (AD).

Dupixent is a human monoclonal antibody that is designed to specifically inhibit overactive signaling of two key proteins, IL-4 and IL-13, which are believed to be major drivers of the persistent underlying inflammation in AD. It comes in a pre-filled syringe and can be self-administered as a subcutaneous injection every other week after an initial loading dose and can be used... more »

AAD Commends FDA for Indoor Tanning Restrictions

The American Academy of Dermatology (AAD) applauds the U.S. Food and Drug Administration (FDA) for proposing new regulations governing indoor tanning, including an age restriction for minors under the age of 18 as well as a risk-acknowledgement form that all adults must sign before using indoor tanning devices.

According to the AAD, statistics show that millions of people tan indoors annually and the risk of developing melanoma increases by 59% for individuals exposed to UV radiation from indoor tanning—the risk increases with each use. If the FDA’s proposed rule becomes final,... more »

ASDS Honored With 14 MarCom Awards

The American Society for Dermatologic Surgery (ASDS) and American Society for Dermatologic Surgery Association (ASDSA) were recognized with 14 awards—including three Platinums—in the 2015 MarCom Awards.

The MarCom Awards competition is administered and judged by the Association of Marketing and Communication Professionals, selecting winners “whose work serves as a benchmark for the industry.” The 2015 competition received about 6,500 entries representing more than a dozen countries.

The Platinum Award—MarCom’s top honor—was presented to ASDS in three categories: Currents... more »